Assessing chronic pain in hemodialysis patients
Chronic Pain in Patients With Chronic Kidney Disease in Hemodialysis
This study looks at how common chronic pain is in patients with kidney failure who are on hemodialysis to see if better pain management should be included in their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cardenal Herrera University Academic / other |
| Locations | 2 sites (Terrassa, Barcelona and 1 other locations) |
| Trial ID | NCT06311240 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the presence and characteristics of chronic pain in patients with End-Stage Renal Disease (ESRD) undergoing hemodialysis. It seeks to highlight the prevalence of pain syndromes in this population, which often goes unrecognized and inadequately managed. By understanding the impact of chronic pain, the study aims to determine the relevance of incorporating pain management into the holistic treatment approaches already being utilized for these patients. The study will involve patients who have been on hemodialysis for at least three months and are medically stable.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with End-Stage Renal Disease who have been on hemodialysis for at least three months and can walk with or without aids.
Not a fit: Patients with recent myocardial infarction, unstable angina, or significant mobility impairments due to cerebrovascular disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for hemodialysis patients, enhancing their quality of life.
How similar studies have performed: Other studies have indicated the importance of addressing chronic pain in similar patient populations, suggesting that this approach could yield beneficial insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with End-Stage Renal Disease (ESRD) * Have been on hemodialysis treatment for at least 3 months and are medically stable. * Able to walk a few steps, even if they require walking aids such as canes or walkers. Exclusion Criteria: * Myocardial infarction in the past 6 weeks. * Unstable angina during exercise or at rest. * Amputation of lower limbs above the knee without prosthetics. * Cerebrovascular disease such as stroke or transient ischemic attacks in the last 6 months or with significant sequelae affecting lower limb mobility. * Musculoskeletal or respiratory disorders that worsen with exercise. * Inability to perform study tests/questionnaires.
Where this trial is running
Terrassa, Barcelona and 1 other locations
- Consorci Sanitari de Terrassa — Terrassa, Barcelona, Spain (Recruiting)
- Universidad Cardenal Herrera-CEU, CEU Universities — Alfara del Patriarca, Valencia, Spain (Not_yet_recruiting)
Study contacts
- Principal investigator: Miriam Garrigós-Pedrón, PhD — Universidad Cardenal Herrera-CEU, CEU Universities
- Study coordinator: Eva F Segura-Ortí, PhD
- Email: ESEGURA@UCHCEU.ES
- Phone: 00034961369000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.